Literature DB >> 25278792

Management strategies for persistent epithelial defects of the cornea.

Lee R Katzman1, Bennie H Jeng1.   

Abstract

Management of patients with persistent epithelial defects of the cornea can be challenging to even the seasoned ophthalmologist. It is essential that one understands not only the pathophysiology of the failure of the epithelium to migrate and close a wound appropriately, but also the mechanism of action of the available treatment modalities at one's disposal. This article serves as a review of current standard therapies, recently introduced alternative therapies gaining in popularity, and a look into the newest developments that may change the way we manage corneal surface disease.

Entities:  

Keywords:  Amniotic membrane; Autologous serum; Non-healing epithelial defect; Persistent epithelial defect; Scleral contact lens

Year:  2014        PMID: 25278792      PMCID: PMC4181455          DOI: 10.1016/j.sjopt.2014.06.011

Source DB:  PubMed          Journal:  Saudi J Ophthalmol        ISSN: 1319-4534


  43 in total

1.  Treatment of severe ocular-surface disorders with corneal epithelial stem cell transplantation.

Authors:  E C Alfonso
Journal:  Arch Ophthalmol       Date:  2000-01

2.  The use of autologous serum tears in persistent corneal epithelial defects.

Authors:  A L Young; A C O Cheng; H K Ng; L L Cheng; G Y S Leung; D S C Lam
Journal:  Eye (Lond)       Date:  2004-06       Impact factor: 3.775

3.  Topical application of autologous adipose-derived mesenchymal stem cells (MSCs) for persistent sterile corneal epithelial defect.

Authors:  George I Agorogiannis; Vassilia-Ismini Alexaki; Ourania Castana; George D Kymionis
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2011-10-20       Impact factor: 3.117

4.  Treatment of chronic nonhealing neurotrophic corneal epithelial defects with thymosin beta 4.

Authors:  Steven P Dunn; David G Heidemann; Christopher Y C Chow; David Crockford; Nabila Turjman; Janet Angel; Christian B Allan; Gabriel Sosne
Journal:  Arch Ophthalmol       Date:  2010-05

5.  Combination of serum eye drops with hydrogel bandage contact lenses in the treatment of persistent epithelial defects.

Authors:  Stefan Schrader; Thilo Wedel; Ralf Moll; Gerd Geerling
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2006-03-17       Impact factor: 3.117

6.  Sutureless amniotic membrane transplantation for partial limbal stem cell deficiency.

Authors:  Ahmad Kheirkhah; Victoria Casas; Vadrevu K Raju; Scheffer C G Tseng
Journal:  Am J Ophthalmol       Date:  2008-03-10       Impact factor: 5.258

7.  Effect of autologous platelet-rich plasma on persistent corneal epithelial defect after infectious keratitis.

Authors:  Kyoung Min Kim; Yong-Tae Shin; Hong Kyun Kim
Journal:  Jpn J Ophthalmol       Date:  2012-09-13       Impact factor: 2.447

8.  Autologous serum eyedrops for dry eyes and epithelial defects: clinical and in vitro toxicity studies.

Authors:  A C Poon; G Geerling; J K Dart; G E Fraenkel; J T Daniels
Journal:  Br J Ophthalmol       Date:  2001-10       Impact factor: 4.638

9.  The evaluation of eye patching in the treatment of traumatic corneal epithelial defects.

Authors:  T M Campanile; D A St Clair; M Benaim
Journal:  J Emerg Med       Date:  1997 Nov-Dec       Impact factor: 1.484

10.  Outcomes of Boston keratoprosthesis implantation for failed keratoplasty after keratolimbal allograft.

Authors:  Joshua H Hou; Jose de la Cruz; Ali R Djalilian
Journal:  Cornea       Date:  2012-12       Impact factor: 2.651

View more
  28 in total

1.  Pathophysiology of Corneal Scarring in Persistent Epithelial Defects After PRK and Other Corneal Injuries.

Authors:  Steven E Wilson; Carla S Medeiros; Marcony R Santhiago
Journal:  J Refract Surg       Date:  2018-01-01       Impact factor: 3.573

2.  Hepatocyte Growth Factor Suppresses Inflammation and Promotes Epithelium Repair in Corneal Injury.

Authors:  Masahiro Omoto; Kunal Suri; Afsaneh Amouzegar; Mingshun Li; Kishore R Katikireddy; Sharad K Mittal; Sunil K Chauhan
Journal:  Mol Ther       Date:  2017-05-11       Impact factor: 11.454

3.  Dry eye and ocular surface disease.

Authors:  Samuel C Yiu
Journal:  Saudi J Ophthalmol       Date:  2014-07

Review 4.  Coordinated Modulation of Corneal Scarring by the Epithelial Basement Membrane and Descemet's Basement Membrane.

Authors:  Steven E Wilson
Journal:  J Refract Surg       Date:  2019-08-01       Impact factor: 3.573

Review 5.  Complications in Retinal Surgery: A Review of Corneal Changes Following Vitreoretinal Procedures.

Authors:  Paula A Sepulveda-Beltran; Harry Levine; Victoria S Chang; Allister Gibbons; Jaime D Martinez
Journal:  Int Ophthalmol Clin       Date:  2022-06-22

6.  Growth factor-eluting hydrogels for management of corneal defects.

Authors:  Clotilde Jumelle; Ehsan Shirzaei Sani; Yukako Taketani; Ann Yung; Fanny Gantin; Sunil K Chauhan; Nasim Annabi; Reza Dana
Journal:  Mater Sci Eng C Mater Biol Appl       Date:  2020-12-10       Impact factor: 7.328

7.  In-situ porcine corneal matrix hydrogel as ocular surface bandage.

Authors:  Ghasem Yazdanpanah; Ritu Shah; Sri Raghurama R Somala; Khandaker N Anwar; Xiang Shen; Seungwon An; Meisam Omidi; Mark I Rosenblatt; Tolou Shokuhfar; Ali R Djalilian
Journal:  Ocul Surf       Date:  2021-04-22       Impact factor: 6.268

8.  Netrin-1 promotes epithelium repair in corneal injury.

Authors:  Yun Han; Nan Jiang; Ting Su; Qi-Chen Yang; Cong-Cong Yan; Lei Ye; Qing Yuan; Pei-Wen Zhu; Wei Li; Zu-Guo Liu; Yi Shao
Journal:  Int J Ophthalmol       Date:  2020-02-18       Impact factor: 1.779

Review 9.  Human Serum Eye Drops in Eye Alterations: An Insight and a Critical Analysis.

Authors:  Maria Rosaria De Pascale; Michele Lanza; Linda Sommese; Claudio Napoli
Journal:  J Ophthalmol       Date:  2015-10-04       Impact factor: 1.909

10.  Hyaluronate Acid-Dependent Protection and Enhanced Corneal Wound Healing against Oxidative Damage in Corneal Epithelial Cells.

Authors:  Jing Zhong; Yuqing Deng; Bishan Tian; Bowen Wang; Yifang Sun; Haixiang Huang; Ling Chen; Shiqi Ling; Jin Yuan
Journal:  J Ophthalmol       Date:  2016-04-14       Impact factor: 1.909

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.